712519008: Daclatasvir (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Hepatitis C virus protein NS5A inhibitor\Daclatasvir (substance)
\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Hepatitis C virus protein NS5A inhibitor\Daclatasvir (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Hepatitis C virus protein NS5A inhibitor\Daclatasvir (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3082832019 Daclatasvir (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3082833012 Daclatasvir en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

51341000195119 daclatasvir it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

803561000172114 daclatasvir fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

65561000195119 Daclatasvir de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Daclatasvir (substance)	Is a	Hepatitis C virus protein NS5A inhibitor	true	Inferred relationship	Some
Daclatasvir (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Hepatitis C virus protein NS5A inhibitor (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing daclatasvir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Daclatasvir (substance)	Inferred relationship	Some	1
Daclatasvir-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Daclatasvir (substance)	Inferred relationship	Some	1
Product containing only daclatasvir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Daclatasvir (substance)	Inferred relationship	Some	1
Product containing only daclatasvir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Daclatasvir (substance)	Inferred relationship	Some	1
Daclatasvir dihydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Daclatasvir (substance)	Inferred relationship	Some
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 60 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Daclatasvir (substance)	Inferred relationship	Some	1
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Daclatasvir (substance)	Inferred relationship	Some	1
Product containing precisely daclatasvir (as daclatasvir dihydrochloride) 90 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Daclatasvir (substance)	Inferred relationship	Some	1

This concept is not in any reference sets